SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Holgerson Bryan

(Last)

(First)

(Middle)

900 COTTAGE GROVE RD

(Street)

BLOOMFIELD

CONNECTICUT

06002

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026

3. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $.01 Par Value	6,957	D
Common Stock, $.01 Par Value	735.9274⁽¹⁾	I	By 401(k)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	03/01/2019⁽²⁾	02/28/2028	Common Stock, $.01 Par Value	1,280	$197.35	D
Employee Stock Option (Right to Buy)	02/27/2020⁽³⁾	02/27/2029	Common Stock, $.01 Par Value	896	$183.4405	D
Employee Stock Option (Right to Buy)	02/26/2021⁽⁴⁾	02/26/2030	Common Stock, $.01 Par Value	915	$192.02	D
Employee Stock Option (Right to Buy)	03/01/2022⁽⁵⁾	02/24/2031	Common Stock, $.01 Par Value	1,071	$213.8	D
Employee Stock Option (Right to Buy)	03/01/2023⁽⁶⁾	02/23/2032	Common Stock, $.01 Par Value	1,124	$227.02	D
Employee Stock Option (Right to Buy)	03/01/2024⁽⁷⁾	02/22/2033	Common Stock, $.01 Par Value	1,568	$294.61	D
Employee Stock Option (Right to Buy)	03/01/2025⁽⁸⁾	02/28/2034	Common Stock, $.01 Par Value	2,978	$336.475	D
Employee Stock Option (Right to Buy)	03/01/2026⁽⁹⁾	02/28/2035	Common Stock, $.01 Par Value	4,790	$305.855	D
Employee Stock Option (Right to Buy)	03/01/2027⁽¹⁰⁾	02/27/2036	Common Stock, $.01 Par Value	4,221	$287.5475	D
Phantom Stock Units	⁽¹¹⁾	⁽¹¹⁾	Common Stock, $.01 Par Value	941.8085	$0	D

Explanation of Responses:

1. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan

2. This option vested in three equal annual installments beginning February 28, 2019.

3. This option vested in three equal annual installments beginning February 27, 2020.

4. This option vested in three equal annual installments beginning February 26, 2021.

5. This option vested in three equal annual installments beginning March 1, 2022.

6. This option vested in three equal annual installments beginning March 1, 2023.

7. This option vested in three equal annual installments beginning March 1, 2024.

8. This option vests in three equal annual installments beginning March 1, 2025.

9. This option vests in three equal annual installments beginning March 1, 2026.

10. This option vests in three equal annual installments beginning March 1, 2027.

11. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

Remarks:

Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes / EX-24 Power of Attorney

	Tyler Gratton, attorney-in-fact	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)